<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Exp Med</journal-id>
      <journal-title>The Journal of Experimental Medicine</journal-title>
      <issn pub-type="ppub">0022-1007</issn>
      <issn pub-type="epub">1540-9538</issn>
      <publisher>
        <publisher-name>The Rockefeller University Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">2139699</article-id>
      <article-id pub-id-type="pmc">2187905</article-id>
      <article-id pub-id-type="publisher-id">90237758</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells</article-title>
      </title-group>
      <pub-date pub-type="ppub">
        <day>1</day>
        <month>5</month>
        <year>1990</year>
      </pub-date>
      <volume>171</volume>
      <issue>5</issue>
      <fpage>1697</fpage>
      <lpage>1704</lpage>
      <permissions/>
      <abstract>
        <p>We have characterized a child with a severe combined immunodeficiency disease syndrome with increased numbers, but a normal distribution, of CD3+ T cells. This patient's immunological defect appears to be attributable to a selective deficiency in T cell production of IL-2, which may reflect a subtle abnormality in the IL-2 gene locus or a defect in a regulatory factor necessary for IL-2 transcription. The increased numbers of phenotypically normal T cells in this patient suggest that alternative pathways of T cell development exist in man or that IL-2 production intra- and extrathymically is controlled via distinct regulatory mechanisms.</p>
      </abstract>
    </article-meta>
  </front>
</article>
</pmc-articleset>
